Justification
Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)
75A50325Q00021
Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending, September 26, 2025, contract GS00F022CA
Description
As published on SAM.gov.
Post-Award Limited Sources Justification (LSJ) - Xofluza (Baloxavir Marboxil)
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Leidos, Inc.
- UEI
- E9BSACNAJ7G1
- CAGE
- 6B6E6
- Vendor location
- Reston, VA
- Contract
- GS00F022CA
- Obligated
- $0.00, potential $1,096,000,000
- Actions
- 22 between January 5, 2024 and June 29, 2026
- Competition
- Full and Open Competition, 999 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- Federal Supply Schedule Contract
- Match
- award number GS00F022CA equals the contract number; awarding office not confirmed (medium confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
October 15, 2025
Justification
SAM.gov, notice 4bbf86fb508c44a5a6c6e1b15beefc5e
Points of contact
- Leatrice BullsOSContracting@hhs.gov
- Kimberly GoldenOSContracting@hhs.gov
Also open from this buyer
- SNS Pharmaceutical Logistic Replenishment RequirementCombined synopsis and solicitationNAICS 325412New York75A50326R00007Closes tomorrowSep 18